Entrada Therapeutics
TRDA
$13.16
Share price
-2.95%
Change (1 day)
10.13%
Change (1 year)
Categories
Entrada Therapeutics (TRDA) - Cash on Hand
Cash on Hand as of December 2023 : $0.35 B
According to Entrada Therapeutics's latest financial reports the company has $0.35 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Entrada Therapeutics - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.35 B | 86.51% |
| 2022-12-31 | $0.18 B | -35.16% |
| 2021-12-31 | $0.29 B | 645.46% |
| 2020-12-31 | $39.04 M | 131.8% |
| 2019-12-31 | $16.84 M |